Back to results
Not yet recruitingPhase 1

Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy

NCT07172971

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Riley Hospital at Indiana University Health

Indianapolis, Indiana, United States

Contact

Larry W Markham, MD

317 944-8906lwmarkha@iu.edu
View on ClinicalTrials.gov
Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy — TrialFind